CHAMPAIN Study: Initial Results from a Phase II Study of Efficacy, Safety and Tolerability of Modified-Release Hydrocortisones: Chronocort® (efmody®) Versus Plenadren®, in Primary Adrenal Insufficiency
Endocrine Abstracts(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要